Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease

Published:2023-08 Issue: Volume:214 Page:115647
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Lai Yujun,Wang Xinhui,Sun Xue,Wu Shuwei,Chen Xin,Yang Chengkui,Zhang Wei,Yu Xiaoliang,Tong Yushan,Ma Feng,Zheng Heng,Zhang Xiaohu,He Sudan^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference53 articles.

1. NOD1 and NOD2: signaling, host defense, and inflammatory disease;Caruso;Immunity,2014

2. Innate immunity signalling and membrane trafficking;Taguchi;Curr. Opin. Cell Biol.,2019

3. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan;Girardin;Science (New York, N.Y.),2003

4. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection;Girardin;J. Biol. Chem.,2003

5. NOD1 and NOD2 in inflammatory and infectious diseases;Trindade;Immunol. Rev.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cells: the yin and yang in disease progression;Frontiers in Immunology;2024-01-04

2. Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review;RSC Medicinal Chemistry;2024

3. Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators;Journal of Neuroinflammation;2023-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP